| Application no. and date | 20900863.0 (espacenet) (Federated) (European Patent Register), 20201218 | | Patent/reg. no. and date | DK/EP 4076461, 20260128 | | Publication date | 20221026 | | Priority no. and date | US 201962950828 P, 20191219 | | EP pub. no. and date |
EP 4076461 20221026 | | Effective date | | | Applicant/owner | Intra-Cellular Therapies, Inc., 135 Route 202/206, Suite 6
Bedminster, NJ 07921, US | | Applicant ref. no. | V502810DK00 | | Inventor | DAVIS, Robert E., c/o Intra-Cellular Therapies, Inc. 430 East 29th
Street Suite 900
New York, New York 10016, US,
VANOVER, Kimberly, c/o Intra-Cellular Therapies, Inc. 430 East 29th
Street Suite 900
New York, New York 10016, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61K 31/4985 (2006.01) , A61K 45/06 (2006.01) , A61P 25/18 (2006.01) , C07D 417/12 (2006.01) | | Title | LUMATEPERON TIL BRUG VED BEHANDLING AF SKIZOFRENI | | Int. application no. | US2020066224 | | Int. publication no. | WO2021127572 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
